Metastatic-promoting effects of LPS: Sexual dimorphism and mediation by catecholamines and prostaglandins

Brain, Behavior, and Immunity

Volumn 23, Issue 5, 2009, Pages 611-621

  Naor, Ranit ^a   Domankevich, Vered ^a   Shemer, Shaily ^a   Sominsky, Luba ^a   Rosenne, Ella ^a   Levi, Ben ^a   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Inflammation; LPS; Metastases; NK; Sex differences

Indexed keywords

CATECHOLAMINE; CORTICOSTERONE; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NADOLOL; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPLETION; FEMALE; FISCHER 344 RAT; IN VIVO STUDY; INFLAMMATION; LUNG METASTASIS; LUNG TUMOR; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN BLOOD LEVEL; RAT; SEX DIFFERENCE;

ADENOCARCINOMA; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CATECHOLAMINES; CELL LINE, TUMOR; CORTICOSTERONE; CYCLOOXYGENASE INHIBITORS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INDOMETHACIN; INTERLEUKIN-6; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NADOLOL; PROSTAGLANDINS; RATS; RATS, INBRED F344; SEX CHARACTERISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949092549     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.10.001     Document Type: Article

References (105)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Almqvist C., Worm M., and Leynaert B. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63 (2008) 47-57
3. Angele M.K., Schwacha M.G., Ayala A., and Chaudry I.H. Effect of gender and sex hormones on immune responses following shock. Shock 14 (2000) 81-90
4. Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., Song X., Dvozkin T., Krelin Y., and Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25 (2006) 387-408
5. Arias J.I., Aller M.A., and Arias J. The use of inflammation by tumor cells. Cancer 104 (2005) 223-228
6. Audoly L.P., Tilley S.L., Goulet J., Key M., Nguyen M., Stock J.L., McNeish J.D., Koller B.H., and Coffman T.M. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am. J. Physiol. 277 (1999) H924-H930
7. Averbeck M., Gebhardt C., Emmrich F., Treudler R., and Simon J.C. Immunologic principles of allergic disease. J. Dtsch. Dermatol. Ges. 5 (2007) 1015-1028
8. Ayala A., Lehman D.L., Herdon C.D., and Chaudry I.H. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch. Surg. 129 (1994) 1172-1178
9. Baker A.E., Brautigam V.M., and Watters J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145 (2004) 5021-5032
10. Baldwin Jr. A.S. Series introduction: the transcription factor NF-kappaB and human disease. J. Clin. Invest. 107 (2001) 3-6
11. Balkwill F., and Coussens L.M. Cancer: an inflammatory link. Nature 431 (2004) 405-406
12. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
13. Barker L.A., Dazin P.F., Levine J.D., and Green P.G. Sympathoadrenal-dependent sexually dimorphic effect of nonhabituating stress on in vivo neutrophil recruitment in the rat. Br. J. Pharmacol. 145 (2005) 872-879
14. Barlozzari T., Reynolds C.W., and Herberman R.B. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J. Immunol. 131 (1983) 1024-1027
15. Barlozzari T., Leonhardt J., Wiltrout R.H., Herberman R.B., and Reynolds C.W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol. 134 (1985) 2783-2789
16. Bar-Yosef S., Melamed R., Page G.G., Shakhar G., Shakhar K., and Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94 (2001) 1066-1073
17. Ben-Eliyahu S., and Page G.G. In vivo assessment of natural killer cell activity in rats. Progress in Neuroendocrinimmunology 5 (1992) 199-214
18. Ben-Eliyahu S., Page G.G., Shakhar G., and Taylor A.N. Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells. Br. J. Cancer 74 (1996) 1900-1907
19. Ben-Eliyahu S., Page G.G., Yirmiya R., and Taylor A.N. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat. Med. 2 (1996) 457-460
20. Ben-Eliyahu S., Page G.G., Yirmiya R., and Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80 (1999) 880-888
21. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., and Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8 (2000) 154-164
22. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., and Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 15 (2008) 2042-2052
23. Benschop R.J., Rodriguez-Feuerhahn M., and Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 10 (1996) 77-91
24. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog. Brain Res. 162 (2007) 3-14
25. Chambers W.H., Vujanovic N.L., DeLeo A.B., Olszowy M.W., Herberman R.B., and Hiserodt J.C. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169 (1989) 1373-1389
26. Chambers W.H., Brumfield A.M., Hanley-Yanez K., Lakomy R., Herberman R.B., McCaslin D.C., Olszowy M.W., and McCoy Jr. J.P. Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.) bright and NKR-P1bright/L.E. dim subpopulations of rat natural killer cells. J. Immunol. 148 (1992) 3658-3665
27. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
28. Da Silva J.A. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann. Rheum. Dis. 54 (1995) 6-16
29. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci. 933 (2001) 222-234
30. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
31. de Coupade C., Gear R.W., Dazin P.F., Sroussi H.Y., Green P.G., and Levine J.D. Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic. Br. J. Pharmacol. 143 (2004) 1033-1041
32. Death A.K., McGrath K.C., Sader M.A., Nakhla S., Jessup W., Handelsman D.J., and Celermajer D.S. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology 145 (2004) 1889-1897
33. Delrue-Perollet C., Li K.S., Vitiello S., and Neveu P.J. Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS. Brain Behav. Immun. 9 (1995) 149-162
34. Deshpande R., Khalili H., Pergolizzi R.G., Michael S.D., and Chang M.D. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am. J. Reprod. Immunol. 38 (1997) 46-54
35. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
36. DunnGalvin A., Hourihane J.O., Frewer L., Knibb R.C., Oude Elberink J.N., and Klinge I. Incorporating a gender dimension in food allergy research: a review. Allergy 61 (2006) 1336-1343
37. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
38. Elkind M.S. Inflammation, atherosclerosis, and stroke. Neurologist 12 (2006) 140-148
39. Evans M.J., Eckert A., Lai K., Adelman S.J., and Harnish D.C. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ. Res. 89 (2001) 823-830
40. Fiuza C., and Suffredini A.F. Human models of innate immunity: local and systemic inflammatory responses. J. Endotoxin Res. 7 (2001) 385-388
41. Grigoriadis S., and Robinson G.E. Gender issues in depression. Ann. Clin. Psychiatry 19 (2007) 247-255
42. Haim S., Shakhar G., Rossene E., Taylor A.N., and Ben-Eliyahu S. Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J. Endocrinol. Invest. 26 (2003) 1013-1022
43. Harden L.M., du Plessis I., Poole S., and Laburn H.P. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol. Behav. 89 (2006) 146-155
44. Harmey J.H., Bucana C.D., Lu W., Byrne A.M., McDonnell S., Lynch C., Bouchier-Hayes D., and Dong Z. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int. J. Cancer 101 (2002) 415-422
45. Hasko G., and Szabo C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem. Pharmacol. 56 (1998) 1079-1087
46. Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., and Szabo C. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br. J. Pharmacol. 125 (1998) 1297-1303
47. Hinz B., and Brune K. Cyclooxygenase-2-10 years later. J. Pharmacol. Exp. Ther. 300 (2002) 367-375
48. Johnson J.D., O'Connor K.A., Hansen M.K., Watkins L.R., and Maier S.F. Effects of prior stress on LPS-induced cytokine and sickness responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R422-R432
49. Kam P.C., and See A.U. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55 (2000) 442-449
50. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
51. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 24 (2000) 627-638
52. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta. Psychiatr. Scand. 108 (2003) 163-174
53. Laroux F.S. Mechanisms of inflammation: the good, the bad and the ugly. Front. Biosci. 9 (2004) 3156-3162
54. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., and Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267 (1992) 25934-25938
55. Lindsberg P.J., and Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (2003) 2518-2532
56. Lowry S.F. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24 Suppl. 1 (2005) 94-100
57. Luo J.L., Maeda S., Hsu L.C., Yagita H., and Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer cell 6 (2004) 297-305
58. Madden K.S. Catecholamines, sympathetic innervation, and immunity. Brain Behav. Immun. 17 Suppl. 1 (2003) S5-S10
59. Marriott I., and Huet-Hudson Y.M. Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 34 (2006) 177-192
60. Marriott I., Bost K.L., and Huet-Hudson Y.M. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J. Reprod. Immunol. 71 (2006) 12-27
61. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., and Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 19 (2005) 114-126
62. Miller J.G., and Mac Neil S. Gender and cutaneous melanoma. Br. J. Dermatol. 136 (1997) 657-665
63. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin. Infect. Dis. 41 Suppl. 7 (2005) S490-S497
64. Ospina J.A., Brevig H.N., Krause D.N., and Duckles S.P. Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H2010-H2019
65. Page G.G., and Ben-Eliyahu S. Indomethacin attenuates the immunosuppressive and tumor-promoting effects of surgery. J. Pain 3 (2002) 301-308
66. Page G.G., Ben-Eliyahu S., and Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 8 (1994) 241-250
67. Page G.G., Fennelly A.M., Littleton-Kearney M.T., and Ben-Eliyahu S. Male-female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J. Neuroimmunol. 193 (2008) 113-119
68. Palsson-McDermott E.M., and O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113 (2004) 153-162
69. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23 (2002) 90-119
70. Pidgeon G.P., Harmey J.H., Kay E., Da Costa M., Redmond H.P., and Bouchier-Hayes D.J. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br. J. Cancer 81 (1999) 1311-1317
71. Poulin R. Helminth growth in vertebrate hosts: does host sex matter?. Int. J. Parasitol. 26 (1996) 1311-1315
72. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
73. Rampen F. Malignant melanoma: sex differences in survival after evidence of distant metastasis. Br. J. Cancer 42 (1980) 52-57
74. Rampen F.H. Sex differences in survival from cutaneous melanoma. Int. J. Dermatol. 23 (1984) 444-452
75. Razmara A., Krause D.N., and Duckles S.P. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1843-H1850
76. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
77. Sahmoun A.E., Case L.D., Santoro T.J., and Schwartz G.G. Anatomical distribution of small cell lung cancer: effects of lobe and gender on brain metastasis and survival. Anticancer Res. 25 (2005) 1101-1108
78. Sakata Y., Morimoto A., and Murakami N. Changes in plasma catecholamines during fever induced by bacterial endotoxin and interleukin-1 beta. Jpn. J. Physiol. 44 (1994) 693-703
79. Schafer T., Bohler E., Ruhdorfer S., Weigl L., Wessner D., Filipiak B., Wichmann H.E., and Ring J. Epidemiology of contact allergy in adults. Allergy 56 (2001) 1192-1196
80. Schroder J., Kahlke V., Staubach K.H., Zabel P., and Stuber F. Gender differences in human sepsis. Arch. Surg. 133 (1998) 1200-1205
81. Scoggins C.R., Ross M.I., Reintgen D.S., Noyes R.D., Goydos J.S., Beitsch P.D., Urist M.M., Ariyan S., Sussman J.J., Edwards M.J., Chagpar A.B., Martin R.C., Stromberg A.J., Hagendoorn L., and McMasters K.M. Gender-related differences in outcome for melanoma patients. Ann. Surg. 243 (2006) 693-698 discussion 698-700
82. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 160 (1998) 3251-3258
83. Shakhar G., and Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol. 10 (2003) 972-992
84. Shiff S.J., Shivaprasad P., and Santini D.L. Cyclooxygenase inhibitors: drugs for cancer prevention. Curr. Opin. Pharmacol. 3 (2003) 352-361
85. Strassmann G., Patil-Koota V., Finkelman F., Fong M., and Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180 (1994) 2365-2370
86. Suffredini A.F., Fantuzzi G., Badolato R., Oppenheim J.J., and O'Grady N.P. New insights into the biology of the acute phase response. J. Clin. Immunol. 19 (1999) 203-214
87. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
88. Taketomi A., Takenaka K., Matsumata T., Shimada M., Higashi H., Shirabe K., Itasaka H., Adachi E., Maeda T., and Sugimachi K. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection. Hepatogastroenterology 44 (1997) 477-483
89. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Lloyd-Jones D., Goff Jr. D.C., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S., Wilson M., and Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
90. Thorvaldsen P., Asplund K., Kuulasmaa K., Rajakangas A.M., and Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 26 (1995) 361-367
91. Tincani A., Andreoli L., Bazzani C., Bosiso D., and Sozzani S. Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun. Rev. 7 (2007) 1-7
92. Tsitoura D.C., and Tassios Y. Immunomodulation: the future cure for allergic diseases. Ann. NY Acad. Sci. 1088 (2006) 100-115
93. Ueda F., Ideguchi K., Taniguchi N., and Kimura K. Adrenergic regulation of prostaglandin biosynthesis in cultured rabbit gastric epithelial cells. Jpn. J. Pharmacol. 65 (1994) 113-120
94. Ulevitch R.J., and Tobias P.S. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11 (1999) 19-22
95. van den Brink M.R., Hunt L.E., and Hiserodt J.C. In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J. Exp. Med. 171 (1990) 197-210
96. Van der Poll T., and Lowry S.F. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am. J. Physiol. 273 (1997) R1885-R1890
97. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol. 1 (2001) 983-993
98. Vidal-Vanaclocha F., Alvarez A., Asumendi A., Urcelay B., Tonino P., and Dinarello C.A. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J. Natl. Cancer Inst. 88 (1996) 198-205
99. Wang Q., Tang X.N., and Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 184 (2007) 53-68
100. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2 (2001) 777-780
101. Wichmann M.W., Inthorn D., Andress H.J., and Schildberg F.W. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 26 (2000) 167-172
102. Woiciechowsky C., Schoning B., Lanksch W.R., Volk H.D., and Docke W.D. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J. Mol. Med. 77 (1999) 769-780
103. Yakar I., Melamed R., Shakhar G., Shakhar K., Rosenne E., Abudarham N., Page G.G., and Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 10 (2003) 469-479
104. Yokotani K., Nishihara M., Murakami Y., Hasegawa T., Okuma Y., and Osumi Y. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors. Br. J. Pharmacol. 115 (1995) 672-676
105. Zhang S., Wan D., Pan Z., Zhou Z., Chen G., Lu Z., Wu X., and Li L. Multiple factors analysis on liver metastasis from colorectal cancer. Zhonghua Zhong Liu Za Zhi 24 (2002) 367-369